Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer“SAN FRANCISCO and SUZHOU, China, Aug. 24, 2025 /PRNewswire/ — Innovent Biologics, Inc....
Neoadjuvant Immunotherapy Shows Promise in Limited-Stage SCLC“Key Takeaways: Neoadjuvant chemoimmunotherapy in LS-SCLC shows high pCR and MPR rates, indicating promising efficacy before surgery. The meta-analysis found a 95% R0 surgical resection rate, with no...
3,000 steps a day at a faster pace may lower cardiovascular risks by 17%“Increasing daily step counts and walking faster may reduce risk of cardiovascular events in people with hypertension, a recent study has found. Walking more than 3,000 steps each day reduced risk...
High risk of hepatic complications in kidney transplantation with chronic hepatitis C virus infection “Data on liver issues including liver cirrhosis, hepatocellular carcinoma, and hepatic failure in renal transplant patients with HCV infection are scarce. In the...
Lung Cancer in Special Populations“Lung cancer is the leading cause of cancer deaths worldwide, claiming more lives than other age-related and screen-detectable cancers. Cigarette smoking remains the most important risk factor. However, despite common perceptions,...
EACH/PIC Releases Results from Patient-Led Survey on Drug Affordability “August 4, 2025 — The Ensuring Access through Collaborative Health and Patient Inclusion Council (EACH/PIC) has released the findings of its new report, Patient Experience Survey: Prescription...
Hepatitis C is a silent epidemic in the U.S., but this small clinic is proving it doesn’t have to be“Although it’s been over a decade since game-changing curative drugs for hepatitis C were approved, progress has been slow and treatment remains out of...
Breakthrough lung cancer treatment supercharges immune cells with mitochondria “Scientists have found a way to supercharge lung cancer treatment by transplanting healthy mitochondria into tumors, which both boosts immune response and makes chemotherapy far more...
Radiation Therapy Overcomes Immunotherapy Resistance in Some Cancers“By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to the treatment, leading to positive outcomes for patients, according to new...
GLP-1 drugs fail to provide key long-term health benefit, study shows“Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in heart and lung function essential for long-term good health, University of...
More News and Updates